RASFFReference 2026.7769
Nieautoryzowana nowa żywność jabłczan kreatyny w suplementach diety pochodzących z Węgier // Tricreatine malate in food supplements originating from Hungary
Official information organised for easier consultation. The source publication remains authoritative.
RASFF
Identification and classification
- Reference
- 2026.7769
- Notification ID
- 870161
- Classification
- information notification for follow-up
- Risk decision
- potential risk
- Product type
- food
- Notification basis
- official control on the market
- Status
- ec_validated
RASFF
Product
- Description
- Suplement diety // Food supplement
- Distribution status
- Description
- information on distribution not (yet) available
- Notification ID
- 221
- Notification ID
- 30990367
- Category
- Description
- dietetic foods, food supplements and fortified foods
- Notification ID
- 18439
- Product descriptions
- Notification ID
- 30990437
- labelling
- -
- productAspect
- opakowanie z tworzywa sztucznego, oznakowane etykietą: BioTech USA TRI-CREATINE MALATE drink powder, unflavoured, 4500mg Tri-creatine malate per serving, 300 grams (66 servings), masa opakowania: 300g, najlepiej spożyć przed: 03/02/2029, nr partii: 1339363
- temperature
- Description
- ambient
- Notification ID
- 27368
- weight
- 300.0
- weightUnit
- Description
- g
- Notification ID
- 18974
RASFF
Risk and analytical results
- Notification ID
- 140970
RASFF
Origin, notification and distribution
- Origin
- Hungary
- Notifying country or territory
- Poland
- Published distribution
- Poland
- Affected territories
- Poland
RASFF
Published territorial roles
- Roles
- Role
- FOR_FOLLOW_UP
- notificationId
- 870161
- Role
- FOR_ATTENTION
- notificationId
- 872051
- Role
- ORIGIN
- notificationId
- 870161
- Role
- OPERATOR
- notificationId
- 870161
- Organisation
- code
- HU
- countryNetworkOrganizationId
- 5017
- Description
- Hungary
- Notification ID
- 52
- Roles
- Role
- NOTIFYING
- notificationId
- 870161
- Role
- NOTIFYING
- notificationId
- 870161
- Role
- DISTRIBUTION
- notificationId
- 870161
- Role
- NOTIFYING
- notificationId
- 870161
- Role
- OPERATOR
- notificationId
- 870161
- Organisation
- code
- PL
- countryNetworkOrganizationId
- 5028
- Description
- Poland
- Notification ID
- 31
RASFF
Follow-ups
- additionalInfoId
- 31005543
- fupDate
- 07-09-2026 11:50:42
- fupId
- 871319
- fupNumber
- 1
- fupType
- Description
- outcome of investigations
- Notification ID
- 27674
- networkOrganizationId
- 52
- organizationCode
- HU
- organizationDescription
- Hungary
- additionalInfoId
- 31010011
- fupDate
- 08-09-2026 12:42:06
- fupId
- 871628
- fupNumber
- 2
- fupType
- Description
- outcome of investigations
- Notification ID
- 27674
- networkOrganizationId
- 31
- organizationCode
- PL
- organizationDescription
- Poland
- additionalInfoId
- 31015775
- fupDate
- 10-09-2026 11:00:08
- fupId
- 872051
- fupNumber
- 3
- fupType
- Description
- request
- Notification ID
- 27665
- networkOrganizationId
- 1
- organizationCode
- EU
- organizationDescription
- European Commission
RASFF
Additional information
- contactPerson
- Agnieszka Świtka - rasff.poland.gis@sanepid.gov.pl
- Notification ID
- 31010011
- Organisation
- Chief Sanitary Inspectorate
- Notification ID
- 31015775
- Organisation
- European Commission
- contactPerson
- Justyna Dublinowska e-mail:justyna.dublinowska@sanepid.gov.pl tel -914849340 / Z. Stępień, M. Owczarek nr tel. 91 462 37 92, e-mail: rasff.wsse.szczecin@sanepid.gov.pl //Agnieszka Świtka - rasff.poland.gis@sanepid.gov.pl
- Notification ID
- 30990368
- Organisation
- PSSE w Szczecinie / WSSE w Szczecinie // Chief Sanitary Inspectorate
- contactPerson
- Szurgent/Kiss
- Notification ID
- 31005543
- Organisation
- Nébih
RASFF
Public links
- 5017
- countryNetworkOrganizationId
- 5017
- Notification ID
- 20
- countryNetworkOrganizationId
- 5017
- Notification ID
- 21
- 5028
- countryNetworkOrganizationId
- 5028
- Notification ID
- 32
Provenance and context
NagameAlert organises public RASFF data while preserving official values and keeping notification classification separate from the risk decision. The official record remains authoritative and should be checked for follow-ups and current status.